Hepatitis C: the clinical spectrum of disease.

Cited by (770)

Items 101–200 of 770

1. Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C
   Robert J. Fontana, Cheryl A. Moyer, Seema S. Sonnad, Anna Suk-Fong Lok, Naomi Sneed-Pee, John James Walsh, Steven Klein, Steven Webster · 2001 · The American Journal of Gastroenterology
2. Symptom Prevalence and Clustering of Symptoms in People Living with Chronic Hepatitis C Infection
   Lang, Carolyn A., Conrad, Sue, Garrett, Lyndall, Battistutta, Diana, Cooksley, W. Graham E., Dunne, Michael P., Macdonald, Graeme A. · 2006 · Journal of Pain and Symptom Management
3. Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis
   Hyosun Cho, Hyojeung Kang, Hwan Lee, Chang Wook Kim · 2017 · International Journal of Molecular Sciences
4. Multicenter Evaluation of the Performance Characteristics of the Bayer VERSANT HCV RNA 3.0 Assay (bDNA)
   Tarek Elbeik, Johan Surtihadi, Mark Destree, Jed B. Gorlin, Mark Holodniy, Saeed A. Jortani, Ken Kuramoto, Valerie L. Ng, Roland Valdes, Alexandra Valsamakis et al. · 2004 · Journal of Clinical Microbiology
5. THE MOLECULAR BIOLOGY OF HEPATITIS C VIRUS
   Xavier Forns, Jens Bukh · 1999 · Clinics in Liver Disease
6. Hepatitis C Virus-Associated Glomerular Disease in Patients with Human Immunodeficiency Virus Coinfection
   Jen-Tse Cheng, Herman L. Anderson, Glen S. Markowitz, Gerald B. Appel, Velvie A. Pogue, Vivette Denise D’Agati · 1999 · Journal of the American Society of Nephrology
7. Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance
   Enea Spada, Alfonso Mele, A Berton, Lionello Ruggeri, Luigina Ferrigno, Anna Rosa Garbuglia, Maria Paola Perrone, G. Girelli, Paola Del Porto, Enza Piccolella et al. · 2004 · Gut
8. Medicinal Herbs for Hepatitis C Virus Infection: A Cochrane Hepatobiliary Systematic Review of Randomized Trials
   Jianping Liu, Eric W. Manheimer, Kiichiro Tsutani, Christian Nyfeldt Gluud · 2003 · The American Journal of Gastroenterology
9. Clinical Spectrum and Histopathologic Features of Chronic Hepatitis C Infection in Children
   Parvathi Mohan, Camilla A. Colvin, Chevelle Glymph, Roma R. Chandra, David Erwin Kleiner, Kantilal M. Patel, Naomi L.C. Luban, Harvey J. Alter · 2007 · The Journal of Pediatrics
10. A Prospective, Community–Based Evaluation of Liver Enzymes in Individuals With Hepatitis C After Drug Use
    Thomas V. Inglesby, Rudra Rai, Jacquie A. Astemborski, Leslie Gruskin, Kenrad E. Nelson, David Vlahov, David L. Thomas · 1999 · Hepatology
11. Differential contribution of hepatitis C virus NS5A and core proteins to the induction of oxidative and nitrosative stress in human hepatocyte-derived cells
    María Victoria García‐Mediavilla, Sonia Sánchez‐Campos, Pilar González-Pérez, Marta Gómez-Gonzalo, Pedro Lorenzo Majano, Manuel López‐Cabrera, Gerardo Clemente, Carmelo García‐Monzón, Javier González‐Gallego · 2005 · Journal of Hepatology
12. IL-10 and TNF-α polymorphisms and the recovery from HCV infection
    Domenico Lio, Calogero Caruso, R. Di Stefano, Giuseppina Colonna Romano, Donatella Ferraro, Letizia Scola, Antonio Crivello, Anna Licata, Lilli Mario Valenza, Giuseppina Candore et al. · 2003 · Human Immunology
13. Biological evaluation of hepatitis c virus helicase inhibitors
    Chee Wee Phoon, Poh Yong Ng, Anthony E. Ting, Su Ling Yeo, Mui Mui Sim · 2001 · Bioorganic & Medicinal Chemistry Letters
14. Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies
    Alberto Larghi, Massimo Giovanni Zuin, Andrea Crosignani, Maria Lisa Ribero, Cristina Pipia, Pier Maria Battezzati, Giorgio Binelli, Francesco Donato, Alessandro Remo Zanetti, Mauro Podda et al. · 2002 · Hepatology
15. Regulatory mechanisms of viral hepatitis B and C
    Gulam Waris, Aleem Siddiqui · 2003 · Journal of Biosciences
16. Sexual transmission of hepatitis C virus infection
    G Rooney, Richard J.C. Gilson · 1998 · Sexually Transmitted Infections
17. Hepatitis B and hepatitis C
    Stephen A. Geller · 2002 · Clinics in Liver Disease
18. Immunopathogenesis of hepatitis C virus infection
    Anthony J. Freeman, George Marinos, Rosemary A. Ffrench, Andrew R. Lloyd · 2001 · Immunology and Cell Biology
19. Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation
    Debbie Hartwell, Jeremy Jones, Louise Baxter, Jonathan Shepherd · 2011 · Health Technology Assessment
20. Dissecting the Interferon-Induced Inhibition of Hepatitis C Virus Replication by Using a Novel Host Cell Line
    Marc Peter Windisch, Michael Frese, Artur Kaul, Martin Trippler, Volker Lohmann, Ralf F. W. Bartenschlager · 2005 · Journal of Virology
21. Hepatitis C Virus Core Protein Down‐Regulates Transcription of Interferon‐Induced Antiviral Genes
    Susana de Lucas, Javier Bartolomé, Vicente Carréño · 2004 · The Journal of Infectious Diseases
22. Interferon‐inducible cholesterol‐25‐hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation
    Anggakusuma, Inés Romero‐Brey, Carola Berger, Che C. Colpitts, Tuyana Boldanova, Michael Engelmann, Daniel Tödt, Paula Monteiro Perin, Patrick Behrendt, Florian W. R. Vondran et al. · 2015 · Hepatology
23. Treatment of hepatitis C
    Andrew I. Kim, Sammy Saab · 2005 · The American Journal of Medicine
24. Hepatitis C virus RNA replication is resistant to tumour necrosis factor-α
    Michael Frese, Kerstin Barth, Artur Kaul, Volker Lohmann, Verena Schwärzle, Ralf F. W. Bartenschlager · 2003 · Journal of General Virology
25. The hepatitis C sequence database in Los Alamos
    CARLA L. KUIKEN, Peter Hraber, Jim Thurmond, Karina Yusim · 2007 · Nucleic Acids Research
26. Poliovirus tropism and attenuation are determined after internal ribosome entry
    Kauder, Steven E., Racaniello, Vincent R. · 2004 · Journal of Clinical Investigation
27. To Interfere and to Anti-interfere: The Interplay Between Hepatitis C Virus and Interferon
    Yupeng He, Michael G. Katze · 2002 · Viral Immunology
28. Illness-related stigma, mood and adjustment to illness in persons with hepatitis C
    Jeannette Golden, Ronán Michael Conroy, Ann Marie O’Dwyer, D. De La Harpe Golden, Jean-Benoît Hardouin · 2006 · Social Science & Medicine
29. Interferon-??-2b Plus Ribavirin
    Lesley J. Scott, Caroline M. Perry · 2002 · Drugs
30. Hepatitis C Virus RNA Synthesis in a Cell-Free System Isolated from Replicon-Containing Hepatoma Cells
    Richard W. Hardy, Joseph Marcotrigiano, Keril J. Blight, John E. Majors, Charles M. Rice · 2003 · Journal of Virology
31. Early virologic response after peginterferon alpha‐2a plus ribavirin or peginterferon alpha‐2b plus ribavirin treatment in patients with chronic hepatitis C*
    Adrian M. Di Bisceglie, Reem H. Ghalib, Fayez M. Hamzeh, Vinod K. Rustgi · 2007 · Journal of Viral Hepatitis
32. First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral decline
    Jennifer E. Layden, Thomas J. Layden, K. Rajender Reddy, Rachel S. Levy‐Drummer, Jennifer J. Poulakos, Avidan Uriel Neumann · 2002 · Journal of Viral Hepatitis
33. Los Alamos Hepatitis C Immunology Database
    Karina Yusim, Russell S. Richardson, Ning Tao, Anita Dalwani, Ashish Kumar Agrawal, James J. Szinger, ROBERT K. FUNKHOUSER, Bette Korber, CARLA L. KUIKEN · 2005 · Applied Bioinformatics
34. Peripheral loss of CD 8+ CD 161++ TCRV α7·2+ mucosal‐associated invariant T cells in chronic hepatitis C virus‐infected patients
    Muttiah Barathan, Rosmawati Mohamed, Jamuna Vadivelu, Li Yen Chang, Alireza Saeidi, Yean Kong Yong, M. Ravishankar Ram, Kaliappan Gopal, Vijayakumar Velu, Marie Larsson et al. · 2015 · European Journal of Clinical Investigation
35. Assessment of Fatigue and Psychologic Disturbances in Patients with Hepatitis C Virus Infection
    Jagdeep S. Obhrai, Yoshio N. Hall, Bhupinderjit S. Anand · 2001 · Journal of Clinical Gastroenterology
36. Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection
    Ke‐Qin Hu, John M. Vierling, Allan G. Redeker · 2001 · Journal of Viral Hepatitis
37. Cost-effectiveness of 24 or 48 weeks of interferon α-2b alone or with ribavirin as initial treatment of chronic hepatitis c
    John B. Wong · 2000 · The American Journal of Gastroenterology
38. E2 of Hepatitis C Virus Inhibits Apoptosis
    Song Hee Lee, Yoon Ki Kim, Chon Saeng Kim, Su Kyoung Seol, Joonhyun Kim, Sungchan Cho, Young-Lan Song, Ralf F. W. Bartenschlager, Sung Key Jang · 2005 · The Journal of Immunology
39. Serum Alanine Aminotransferase in Hepatitis C Screening of Patients on Hemodialysis
    Sammy Saab, Paul Martin, Maria Brezina, Gary Gitnick, Hal F. Yee · 2001 · American Journal of Kidney Diseases
40. Perspectives for the Treatment of Infections with Flaviviridae
    Pieter Leyssen, Erik De Clercq, Johan H. Neyts · 2000 · Clinical Microbiology Reviews
41. A Follow‐Up Study of Morbidity and Mortality Associated with Hepatitis C Virus Infection and Its Interaction with Human T Lymphotropic Virus Type I in Miyazaki, Japan
    Cynthia Boschi‐Pinto, Sherri Oliver Stuver, Akihiko Okayama, Dimitrios Trichopoulos, Endel John Orav, Hirohito Tsubouchi, Nancy E. Mueller · 2000 · The Journal of Infectious Diseases
42. Hepatitis C Virus NS2/3 Processing Is Required for NS3 Stability and Viral RNA Replication
    Sarah Welbourn, Robin Green, Isabelle Gamache, Serge Dandache, Volker Lohmann, Ralf F. W. Bartenschlager, Karen Meerovitch, Arnim Pause · 2005 · Journal of Biological Chemistry
43. Study of host‐ and virus‐related factors associated with spontaneous hepatitis C virus clearance
    Laurent Alric, M. Fort, Jacques Izopet, J.P. Vinel, C. Bureau, K Sandre, Jean-Paul Charlet, Mickael Beraud, Michel Abbal, Michel Duffaut · 2000 · Tissue Antigens
44. Ribavirin plus interferon versus interferon for chronic hepatitis C
    Jesper Sune Brok, Lise Lotte Gluud, Christian Nyfeldt Gluud · 2010 · Cochrane Database of Systematic Reviews
45. Characterization of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis C virus core and envelope proteins 1 and 2
    Turaya Naas, Masoud Ghorbani, Ikuri Álvarez-Maya, Michael Lapner, Rashmi Kothary, Yves De Repentigny, Susantha Gomes, Lorne A. Babiuk, Antonio Giulivi, Catalina Soare et al. · 2005 · Journal of General Virology
46. Evaluation of Liver Function
    Matthew R. Pincus, Philip M. Tierno, Maly Fenelus, Wilbur Bo Bowne, Martin H. Bluth · 2011 · Elsevier eBooks
47. Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor α and carnitine palmitoyl acyl-CoA transferase 1A
    Cheng Hsun Yang · 2005 · World Journal of Gastroenterology
48. The experience of fatigue for people living with hepatitis C
    Glacken, Michèle, Coates, Vivien, Kernohan, George, Hegarty, John · 2003 · Journal of Clinical Nursing
49. The Multifaceted Roles of Autophagy in Flavivirus-Host Interactions
    Po‐Yuan Ke · 2018 · International Journal of Molecular Sciences
50. Chutes and ladders in hepatitis C nucleoside drug development
    Steven J. Coats, Ethel C. Garnier‐Amblard, Franck Amblard, Maryam Ehteshami, Sheida Amiralaei, Hongwang Zhang, Longhu Zhou, Sébastien Bouclé, Xiao Lu, Lavanya Bondada et al. · 2013 · Antiviral Research
51. Assessment of Fatigue in Patients with Chronic Hepatitis C Using the Fatigue Impact Scale
    Ziad Hassoun, Bernard E Willems, Julie Deslauriers, Bich Nguyen, Pierre–Michel Huet · 2002 · Digestive Diseases and Sciences
52. Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma
    Fabio Farinati, Romilda Cardin, Marina Bortolami, Patrizia Burra, Francesco Paolo Russo, Massimo Rugge, M. Guido, Adriana Sergio, Remo Naccarato · 2007 · Journal of Viral Hepatitis
53. Hepatitis C virus: How genetic variability affects pathobiology of disease
    Kazuaki Chayama, Clair Nelson Hayes · 2011 · Journal of Gastroenterology and Hepatology
54. The regulation of hepatitis C virus (HCV) internal ribosome-entry site-mediated translation by HCV replicons and nonstructural proteins
    Yupeng He, Wei Yan, Carlos Coito, Yu Li, Michael Gale, Michael G. Katze · 2003 · Journal of General Virology
55. Smoking and Alanine Aminotransferase Levels in Hepatitis C Virus Infection
    Chong-Shan Wang, Shan‐Tair Wang, Ting‐Tsung Chang, Wei‐Jen Yao, Pesus Chou · 2002 · Archives of Internal Medicine
56. Transmission of Hepatitis C Virus Among People Who Inject Drugs: Viral Stability and Association With Drug Preparation Equipment
    Juliane Doerrbecker, Patrick Behrendt, Pedro Mateu‐Gelabert, Sandra Ciesek, Nina Riebesehl, Corinne Wilhelm, Joerg Steinmann, Thomas Pietschmann, Eike Steinmann · 2012 · The Journal of Infectious Diseases
57. Hepatitis C virus genotype does not affect patient survival among renal transplant candidates
    Svetlozar N. Natov, Johnson Y.N. Lau, Robin Ruthazer, Christopher H. Schmid, Andrew S. Levey, Brian J.G. Pereira · 1999 · Kidney International
58. Dynamics of Alanine Aminotransferase During Hepatitis C Virus Treatment
    Ruy Miguel Ribeiro, Jennifer E. Layden‐Almer, Kimberly A. Powers, Thomas J. Layden, Alan S. Perelson · 2003 · Hepatology
59. Structure-Based Mutational Analysis of the Hepatitis C Virus NS3 Helicase
    Chun-Ling Tai, Wen-Ching Pan, Shwu‐Huey Liaw, Ueng‐Cheng Yang, Lih‐Hwa Hwang, Ding‐Shinn Chen · 2001 · Journal of Virology
60. Diagnosed with Hepatitis C: a descriptive exploratory study
    Michèle Glacken, George W. Kernohan, VIVIEN E. COATES · 2001 · International Journal of Nursing Studies
61. Detection limit of architect hepatitis C core antigen assay in correlation with HCV RNA, and renewed confirmation algorithm for reactive anti-HCV samples
    Cornelia Ottiger, Nicole Gygli, Andreas Huber · 2013 · Journal of Clinical Virology
62. Transcriptional Activation of the Interleukin-2 Promoter by Hepatitis C Virus Core Protein
    Anders Bergqvist, Charles M. Rice · 2001 · Journal of Virology
63. Relative impact of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in chronic hepatitis C infection
    Ludwig Kramer, Harald Hofer, Edith Bauer, Georg‐Christian Funk, Elisabeth Formann, Petra Steindl‐Munda, Péter Ferenci · 2005 · AIDS
64. Hepatitis C Virus Subgenomic Replicons in the Human Embryonic Kidney 293 Cell Line
    Samir Ali, Charles Pellerin, Daniel Lamarre, George Kukolj · 2003 · Journal of Virology
65. Long‐term outcome of vertically acquired and post‐transfusion hepatitis C infection in children
    Sanguansak Rerksuppaphol, Winita Hardikar, Gregory J. Dore · 2004 · Journal of Gastroenterology and Hepatology
66. A genome-wide association study of HCV-induced liver cirrhosis in the Japanese population identifies novel susceptibility loci at the MHC region
    Yuji Urabe, Hidenori Ochi, Naoya Kato, Vinod Kumar, Atsushi Takahashi, Ryosuke Muroyama, Naoya Hosono, Motoyuki Otsuka, Ryosuke Tateishi, Paulisally Hau Yi Lo et al. · 2013 · Journal of Hepatology
67. Psychiatric Morbidity and its Effect on the Quality of Life of Patients with Chronic Hepatitis B and Hepatitis C
    Mine Özkan, Aytül Çorapçıoğlu, İbrahim Cüneyt Balcıoğlu, Erhan Ertekin, Sila Khan, Samuray Özdemir, Deniz Karayün, Barış Önen Ünsalver, Nazmiye Kocaman, Sabahattin Kaymakglu et al. · 2006 · The International Journal of Psychiatry in Medicine
68. Studies of Hepatitis C Virus in Chimpanzees and Their Importance for Vaccine Development
    Jens Bukh, Xavier Forns, Suzanne Urjil Emerson, Robert H. Purcell · 2001 · Intervirology
69. Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus†
    Narayan Dharel, Naoya Kato, Ryosuke Muroyama, Hiroyoshi Taniguchi, Motoyuki Otsuka, Yue Wang, Amarsanaa Jazag, Run–Xuan Shao, Jin‐Hai Chang, Mark K. Adler et al. · 2008 · Hepatology
70. The functional RNA domain 5BSL3.2 within the NS5B coding sequence influences hepatitis C virus IRES-mediated translation
    Cristina Romero‐López, Alfredo Berzal‐Herranz · 2011 · Cellular and Molecular Life Sciences
71. Targeting Lipid Metabolism in the Treatment of Hepatitis C Virus Infection
    Fumitake Amemiya, Shinya Maekawa, Yoshie Itakura, Asuka Kanayama, Akira Matsui, Shinichi Takano, Tatsuya Yamaguchi, Jun Itakura, Takatoshi Kitamura, Taisuke Inoue et al. · 2008 · The Journal of Infectious Diseases
72. Global elimination of hepatitis C virus infection: Progresses and the remaining challenges
    Reza Taherkhani, Fatemeh Farshadpour · 2017 · World Journal of Hepatology
73. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review
    Malik Sallam, Roaa Khalil · 2024 · Microorganisms
74. Repression of Interferon Regulatory Factor 1 by Hepatitis C Virus Core Protein Results in Inhibition of Antiviral and Immunomodulatory Genes
    Anna Rita Ciccaglione, Emilia Stellacci, Cinzia Marcantonio, Valentina Muto, Michele Equestre, Giulia Marsili, Maria Rapicetta, Angela Battistini · 2006 · Journal of Virology
75. Natural history of hepatitis C virus infection
    Deepak Narayan Amarapurkar · 2000 · Journal of Gastroenterology and Hepatology
76. Mechanisms of Methods for Hepatitis C Virus Inactivation
    Stephanie Pfaender, Janine Brinkmann, Daniel Tödt, Nina Riebesehl, Joerg Steinmann, Jochen Steinmann, Thomas Pietschmann, Eike Steinmann · 2014 · Applied and Environmental Microbiology
77. Acute Disseminated Encephalomyelitis Associated With Hepatitis C Virus Infection
    Sabrina Sacconi, Leonardo Salviati, Elisa Merelli · 2001 · Archives of Neurology
78. Hepatitis C virus (HCV) infection and cryoglobulinemia: Analysis of whole blood and plasma HCV-RNA concentrations and correlation with liver histology
    Warren N. Schmidt, Jack T. Stapleton, Douglas R. LaBrecque, Frank A. Mitros, Patricia Kirby, Mary Jeanne Perino Phillips, Donna L. Brashear · 2000 · Hepatology
79. Two pathogen reduction technologies—methylene blue plus light and shortwave ultraviolet light—effectively inactivate hepatitis C virus in blood products
    Eike Steinmann, Ute Gravemann, Martina Friesland, Juliane Doerrbecker, Thomas H. Müller, Thomas Pietschmann, Axel W. Seltsam · 2012 · Transfusion
80. Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles
    Carine Brinster, Margaret Chen, Delphine Boucreux, Gláucia Paranhos‐Baccalà, Peter Liljeström, François Lemmonier, Geneviève Inchauspé · 2002 · Journal of General Virology
81. Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center
    Xavier Forns, Sergi Ampurdanés, J.M. Sánchez‐Tapias, Magda Guilera, Miquel Sans, Alberto Sanchez Fueyo, Llorenç Quintó, Pedro Joya, Miquel Bruguera, Juan Rodés · 2001 · Journal of Hepatology
82. Combining 3-D Quantitative Structure−Activity Relationship with Ligand Based and Structure Based Alignment Procedures for in Silico Screening of New Hepatitis C Virus NS5B Polymerase Inhibitors
    Ira Musmuca, Antonia Caroli, Antonello Mai, Neerja Kaushik‐Basu, Payal Arora, Rino Ragno · 2010 · Journal of Chemical Information and Modeling
83. Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature
    Surabhi Kumble Basnayake, Philippa Easterbrook · 2016 · Journal of Viral Hepatitis
84. Histological Damage in Chronic Hepatitis C Is Not Related to the Extent of Infection in the Liver
    Elena Rodríguez‐Iñigo, Javier Bartolomé, Susana de Lucas, Félix Manzarbeitia, Margarita Pardo, Carlos Arocena, Jaime Gosálvez, Horacio Oliva, Vicente Carréño · 1999 · American Journal Of Pathology
85. Sexually acquired hepatitis
    M. Gary Brook · 2002 · Sexually Transmitted Infections
86. Clinical Presentation, Outcome, and Response to Therapy Among Patients With Acute Exacerbation of Chronic Hepatitis C
    Evangelista Sagnelli, Mariantonietta Pisaturo, Maria Stanzione, Vincenzo Messina, Loredana Alessio, Caterina Sagnelli, Mario Starace, Giuseppe Di Pasquale, Nicola Coppola · 2013 · Clinical Gastroenterology and Hepatology
87. Hepatitis C Virus Core Protein: An Update on Its Molecular Biology, Cellular Functions and Clinical Implications
    Mohammad Irshad, Indranil Dhar · 2006 · Medical Principles and Practice
88. Human leukocyte antigen class II associations with hepatitis C virus clearance and virus‐specific CD4 T cell response among Caucasians and African Americans†
    Rebecca A. Harris, Kazushi Sugimoto, David Edward Kaplan, Fusao Ikeda, Malek Kamoun, Kyong‐Mi Chang · 2008 · Hepatology
89. A Randomized Intervention Trial to Reduce the Lending of Used Injection Equipment Among Injection Drug Users Infected With Hepatitis C
    Mary H. Latka, Holly Hagan, Farzana Kapadia, Elizabeth T. Golub, Sebastian Bonner, Jennifer V. Campbell, Micaela H. Coady, Richard S. Garfein, Minya Pu, Dave L. Thomas et al. · 2008 · American Journal of Public Health
90. Advances in nucleoside monophosphate prodrugs as anti-HCV agents
    Drew R. Bobeck, Raymond F. Schinazi, Steven J. Coats · 2010 · Antiviral Therapy
91. Ribavirin plus interferon versus interferon for chronic hepatitis C
    Jesper Sune Brok, Lise Lotte Gluud, Christian Nyfeldt Gluud · 2005 · Cochrane Database of Systematic Reviews
92. Hepatitis C Virus Detection Model by Using Random Forest, Logistic-Regression and ABC Algorithm
    Tzuu‐Hseng S. Li, Huan-Jung Chiu, Ping‐Huan Kuo · 2022 · IEEE Access
93. Implication of normal liver enzymes in liver disease
    Vincenza Calvaruso, Antonio Craxı̀ · 2009 · Journal of Viral Hepatitis
94. Quality of life in HCV‐infection: lack of association with ALT levels
    Emma Ruth Miller, Janet E. Miller, David Shaw · 2001 · Australian and New Zealand Journal of Public Health
95. The Role of Humoral Innate Immunity in Hepatitis C Virus Infection
    Alexander W. Tarr, Richard A. Urbanowicz, Jonathan K. Ball · 2012 · Viruses
96. Depressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1
    Murakami, Yuki, Ishibashi, Takaaki, Tomita, Eiichi, Imamura, Yukio, Tashiro, Tomoyuki, Watcharanurak, Kanitta, Nishikawa, Makiya, Takahashi, Yuki, Takakura, Yoshinobu, Mitani, Satoko et al. · 2016 · Scientific Reports
97. Incident hepatitis C virus infection in a community‐based population in Japan
    Akira Okayama, Sherri Oliver Stuver, Edward Tabor, Nobuyoshi TACHIBANA, Michinori Kohara, Nancy E. Mueller, Hirohito Tsubouchi · 2002 · Journal of Viral Hepatitis
98. Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels
    Bernd Kronenberger, Brigitte Rüster, Jung-Hun Lee, Christoph Sarrazin, W. Kurt Roth, Günter Herrmann, Stefan Zeuzem · 2000 · Journal of Hepatology
99. Hepatitis C: epidemiology and review of complementary/alternative medicine treatments.
    Lyn Patrick · 1999 · PubMed
100. The Relationship of Histologic Activity to Serum ALT, HCV genotype and HCV RNA titers in Chronic Hepatitis C
     Young Sok Lee, Seung Kew Yoon, Eun Sun Chung, Si Hyun Bae, Jong Young Choi, Joon‐Yeol Han, Kyu Won Chung, Hee Sik Sun, Boo Sung Kim, Byung Ki Kim · 2001 · Journal of Korean Medical Science